이주영 교수
Lee, Joo Young
- 02-2164-4095
- joolee@catholic.ac.kr
- 정진석추기경약학관 NP517
연구분야
예방약학, 독성학, 선천면역, 염증성질환
연구실적
-
2024.12
| 공동저자
| BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 제29권 6호, pp.1108-1117
Safe and efficient treatment of drug-resistant colorectal cancer cells using kaempferol-loaded exosomes -
2024.12
| 공동저자
| CELLULAR AND MOLECULAR LIFE SCIENCES, 제81권 1호
SPOP-mediated RIPK3 destabilization desensitizes LPS/sMAC/zVAD-induced necroptotic cell death -
2024.10
| 공동저자
| CELL DEATH DISCOVERY, 제10권 1호
RSK2-mediated cGAS phosphorylation induces cGAS chromatin-incorporation-mediated cell transformation and cancer cell colony growth -
2024.10
| 교신저자
| TOXICOLOGICAL RESEARCH, 제40권 4호, pp.683-695
Hepatocyte-specific RIG-I loss attenuates metabolic dysfunction-associated steatotic liver disease in mice via changes in mitochondrial respiration and metabolite profiles -
2024.09
| 공동저자
| ADVANCED DRUG DELIVERY REVIEWS, 제212권
Selective delivery of imaging probes and therapeutics to the endoplasmic reticulum or Golgi apparatus: Current strategies and beyond -
2024.09
| 교신저자
| DRUG TARGETS AND THERAPEUTICS, 제3권 2호, pp.185-197
Exosome-Mediated Communication between Tumors and Immune Cells and Therapeutic Prospects for Anticancer Therapy -
2024.07
| 공동저자
| TOXICOLOGICAL RESEARCH, 제40권 3호, pp.421-429
Risk assessment of cyclohexasiloxane D6 in cosmetic products -
2024.07
| 교신저자
| TOXICOLOGICAL RESEARCH, 제40권 3호, pp.361-375
Safety assessment of cocamidopropyl betaine, a cosmetic ingredient -
2024.07
| 공동저자
| MACROMOLECULAR BIOSCIENCE, 제24권 7호
Beyond Nanoparticle-Based Intracellular Drug Delivery: Cytosol/Organelle-Targeted Drug Release and Therapeutic Synergism -
2024.06
| 공동저자
| BIOMATERIALS SCIENCE, 제12권 12호, pp.3045-3067
Beyond nanoparticle-based oral drug delivery: transporter-mediated absorption and disease targeting -
2024.04
| 공동저자
| CELL DEATH & DISEASE, 제15권 4호
ELK3 destabilization by speckle-type POZ protein suppresses prostate cancer progression and docetaxel resistance -
2024.04
| 공동저자
| SCIENTIFIC REPORTS, 제14권 1호
Ribosomal S6 kinase 2-forkhead box protein O4 signaling pathway plays an essential role in melanogenesis -
2024.03
| 공동저자
| EXPERIMENTAL AND MOLECULAR MEDICINE, 제56권, pp.686-699
Dysregulated CREB3 cleavage at the nuclear membrane induces karyoptosis-mediated cell death -
2024.03
| 교신저자
| DRUG TARGETS AND THERAPEUTICS, 제3권 1호, pp.14-21
A Novel Role of Butaclamol as an Inhibitor of cGAS in Innate Immune Cells -
2024.02
| 공동저자
| ARCHIVES OF PHARMACAL RESEARCH, 제47권 2호, pp.111-126
Comparative metabolism of aschantin in human and animal hepatocytes -
2024.01
| 공동저자
| TOXICOLOGICAL RESEARCH, 제40권 1호, pp.125-137
Comparative metabolism of fargesin in human, dog, monkey, mouse, and rat hepatocytes -
2023.09
| 공동저자
| FOOD AND CHEMICAL TOXICOLOGY, 제179권
Toxicokinetics and tissue distribution of phalloidin in mice -
2023.06
| 교신저자
| ARCHIVES OF PHARMACAL RESEARCH, 제46권 6호, pp.500-534
Beyond DNA sensing: expanding the role of cGAS/STING in immunity and diseases -
2023.06
| 교신저자
| BIOMEDICINE & PHARMACOTHERAPY, 제162권
Regnase-1 plays an essential role in maintaining skin immune homeostasis via regulation of chemokine expression -
2023.01
| 공동저자
| CHEMICAL ENGINEERING JOURNAL, 제456권
e-Poly(L-lysine)-based bioreducible nanogels for mitochondria-targeted delivery and release: Hydrophobicity-tuned nucleus-to-mitochondria organelle-targeting switch and slow disulfide cleavage -
2023.01
| 공동저자
| ARCHIVES OF PHARMACAL RESEARCH, 제46권 1호, pp.44-58
MEKs/ERKs-mediated FBXO1/E2Fs interaction interference modulates G(1)/S cell cycle transition and cancer cell proliferation -
2022.10
| 교신저자
| FRONTIERS IN MOLECULAR BIOSCIENCES, 제9권
Inflammasomes and their roles in arthritic disease pathogenesis -
2022.09
| 교신저자
| BIOMOLECULES & THERAPEUTICS
Loganin Prevents Hepatic Steatosis by Blocking NLRP3 Inflammasome Activation -
2022.04
| 공동저자
| PHARMACEUTICS, 제14권 4호
Toxicokinetics of β-Amanitin in Mice and In Vitro Drug–Drug Interaction Potential -
2022.01
| 공동저자
| EXPERIMENTAL AND MOLECULAR MEDICINE, 제54권 1호, pp.35-46
FBXW7-mediated ERK3 degradation regulates the proliferation of lung cancer cells -
2022.01
| 공동저자
| BIOMATERIALS, 제280권
Beyond hydrophilic polymers in amphiphilic polymer-based self-assembled NanoCarriers: Small hydrophilic carboxylate-capped disulfide drug delivery system and its multifunctionality and multispatial targetability -
2021.12
| 공동저자
| ARCHIVES OF PHARMACAL RESEARCH
Kaempferol sensitizes cell proliferation inhibition in oxaliplatin-resistant colon cancer cells -
2021.11
| 교신저자
| PHARMACEUTICALS, 제14권 11호
Rig-i deficiency promotes obesity-induced insulin resistance -
2021.11
| 교신저자
| JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A, 제84권 22호, pp.922-931
Topical application of celastrol alleviates atopic dermatitis symptoms mediated through the regulation of thymic stromal lymphopoietin and group 2 innate lymphoid cells -
2021.10
| 공동저자
| JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A, 제84권 20호, pp.821-835
Pharmacokinetics of α-amanitin in mice using liquid chromatography-high resolution mass spectrometry and in vitro drug–drug interaction potentials -
2021.09
| 공동저자
| 대한암예방학회지, 제26권 3호, pp.174-182
F-box Protein βTrCP1 Is a Substrate of Extracellular Signal-regulated Kinase 2 -
2021.05
| 공동저자
| JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B, 제24권 4호, pp.137-161
Current opinion on risk assessment of cosmetics -
2021.03
| 교신저자
| CELLS, 제10권 3호
Oxidized Phospholipids in Tumor Microenvironment Stimulate Tumor Metastasis via Regulation of Autophagy -
2021.02
| 공동저자
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 제22권 3호
A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer's and Parkinson's Disease -
2021.02
| 공동저자
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 제22권 4호, pp.1-18
Fargesin inhibits egf-induced cell transformation and colon cancer cell growth by suppression of CDK2/cyclin E signaling pathway -
2021.02
| 공동저자
| ADVANCED FUNCTIONAL MATERIALS, 제31권 6호
Disrupting the Redox Balance with a Diselenide Drug Delivery System: Synergistic or Antagonistic? -
2021.02
| 공동저자
| PHARMACEUTICS, 제13권 2호
Tetrahydrofurofuranoid lignans, eudesmin, fargesin, epimagnolin a, magnolin, and yangambin inhibit UDP-glucuronosyltransferase 1A1 and 1A3 activities in human liver microsomes -
2021.02
| 교신저자
| MOLECULES, 제26권 4호
Loganin alleviates gout in ammation by suppressing NLRP3 in ammasome activation and mitochondrial damage -
2021.02
| 교신저자
| FRONTIERS IN IMMUNOLOGY, 제11권
Regulation of the NLRP3 Inflammasome by Post-Translational Modifications and Small Molecules -
2021.01
| 교신저자
| ARCHIVES OF PHARMACAL RESEARCH, 제44권 1호, pp.16-35
Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases -
2020.11
| 공동저자
| PHARMACEUTICS, 제12권 11호, pp.1-18
Inhibitory effect of AB-PINACA, indazole carboxamide synthetic cannabinoid, on human major drug-metabolizing enzymes and transporters -
2020.10
| 교신저자
| TOXICOLOGICAL RESEARCH, 제36권 4호, pp.329-336
Para-phenylenediamine, an oxidative hair dye ingredient, increases thymic stromal lymphopoietin and proinflammatory cytokines causing acute dermatitis -
2020.09
| 교신저자
| BIOMOLECULES & THERAPEUTICS, 제28권 5호, pp.437-442
Repurposing Auranofin, an Anti-Rheumatic Gold Compound, to Treat Acne Vulgaris by Targeting the NLRP3 Inflammasome -
2020.09
| 공동저자
| EXPERIMENTAL AND MOLECULAR MEDICINE, 제52권 9호, pp.1526-1536
Stat2 stability regulation: an intersection between immunity and carcinogenesis -
2020.08
| 공동저자
| BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 제1866권 8호
Mitochondria-targeted drug delivery in cancers -
2020.07
| 교신저자
| ARTHRITIS & RHEUMATOLOGY, 제72권 7호, pp.1192-1202
Direct Binding to NLRP3 Pyrin Domain as a Novel Strategy to Prevent NLRP3-Driven Inflammation and Gouty Arthritis -
2020.06
| 공동저자
| PHARMACEUTICS, 제12권 6호
Effects of Decomplexation Rates on Ternary Gene Complex Transfection with alpha-Poly(L-Lysine) or epsilon-Poly(L-Lysine) as a Decomplexation Controller in An Easy-To-Transfect Cell or A Hard-To-Transfect Cell -
2020.04
| 교신저자
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 제21권 8호
Sweroside Prevents Non-Alcoholic Steatohepatitis by Suppressing Activation of the NLRP3 Inflammasome -
2020.04
| 교신저자
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 제21권 8호
Skin Barrier Abnormalities and Immune Dysfunction in Atopic Dermatitis -
2020.03
| 공동저자
| MOLECULES, 제25권 5호
Liquid chromatography-tandem mass spectrometry for the simultaneous determination of doxorubicin and its metabolites doxorubicinol, doxorubicinone, doxorubicinolone, and 7-deoxydoxorubicinone in mouse plasma -
2020.01
| 공동저자
| PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 제117권 1호, pp.584-594
FBXW7-mediated stability regulation of signal transducer and activator of transcription 2 in melanoma formation -
2019.12
| 공동저자
| COLLOIDS AND SURFACES B-BIOINTERFACES, 제184권
Controlling complexation/decomplexation and sizes of polymer-based electrostatic pDNA polyplexes is one of the key factors in effective transfection -
2019.08
| 교신저자
| SCIENTIFIC REPORTS, 제9권
Inhibition of NLRP3 inflammasome in tumor microenvironment leads to suppression of metastatic potential of cancer cells -
2019.08
| 공동저자
| MOLECULES, 제24권 16호
In vitro inhibitory effects of APINACA on human major cytochrome P450, UDP-glucuronosyltransferase enzymes, and drug transporters -
2019.07
| 공동저자
| PHARMACEUTICS, 제11권 7호
Identification of catalposide metabolites in human liver and intestinal preparations and characterization of the relevant sulfotransferase, UDP-glucuronosyltransferase, and carboxylesterase enzymes -
2019.07
| 공동저자
| JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 제82권 11호, pp.678-695
Risk assessment of volatile organic compounds (VOCs) detected in sanitary pads -
2019.07
| 공동저자
| MOLECULAR CARCINOGENESIS, 제58권 7호, pp.1221-1233
Epimagnolin targeting on an active pocket of mammalian target of rapamycin suppressed cell transformation and colony growth of lung cancer cells -
2019.06
| 교신저자
| MOLECULES, 제24권 11호
Epigallocatechin-3-gallate prevents acute gout by suppressing NLRP3 inflammasome activation and mitochondrial DNA synthesis -
2019.04
| 공동저자
| TOXICOLOGICAL RESEARCH, 제35권 2호, pp.131-136
Risk Assessment of Ethylhexyl Dimethyl PABA in Cosmetics -
2019.04
| 공동저자
| TOXICOLOGICAL RESEARCH, 제35권 2호, pp.103-117
Risk Assessment of 5-Chloro-2-Methylisothiazol-3(2H)-One/ 2-Methylisothiazol-3(2H)-One (CMIT/MIT) Used as a Preservative in Cosmetics -
2019.04
| 공동저자
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 제20권 8호
RSK2-Mediated ELK3 Activation Enhances Cell Transformation and Breast Cancer Cell Growth by Regulation of c-fos Promoter Activity -
2019.04
| 교신저자
| BIOMEDICINE & PHARMACOTHERAPY, 제112권
Immunostimulatory activity of Y-shaped DNA nanostructures mediated through the activation of TLR9 -
2019.04
| 교신저자
| TOXICOLOGICAL RESEARCH, 제35권 2호, pp.119-129
Risk Assessment of Drometrizole, a Cosmetic Ingredient used as an Ultraviolet Light Absorber -
2019.04
| 공동저자
| TOXICOLOGICAL RESEARCH, 제35권 2호, pp.137-154
Risk Assessment of Triclosan, a Cosmetic Preservative -
2019.02
| 공동저자
| MOLECULES, 제24권 4호
In Vitro Metabolism of 25B-NBF, 2-(4-Bromo-2, 5-Dimethoxyphenyl)-N-(2-Fluorobenzyl)ethanamine, in Human Hepatocytes Using Liquid Chromatography–Mass Spectrometry -
2019.01
| 공동저자
| MOLECULAR CARCINOGENESIS, 제58권 1호, pp.88-101
Magnolin targeting of ERK1/2 inhibits cell proliferation and colony growth by induction of cellular senescence in ovarian cancer cells -
2018.12
| 교신저자
| PHYTOTHERAPY RESEARCH, 제32권 12호, pp.2551-2559
Licochalcone A attenuates acne symptoms mediated by suppression of NLRP3 inflammasome -
2018.10
| 교신저자
| ADVANCED FUNCTIONAL MATERIALS, 제28권 40호, pp.201801918-201801918
Efficient Transdermal Delivery of DNA Nanostructures Alleviates Atopic Dermatitis Symptoms in NC/Nga Mice -
2018.10
| 공동저자
| ACTA PHARMACEUTICA SINICA B, 제8권 6호, pp.862-880
Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives -
2018.09
| 교신저자
| BIOMOLECULES & THERAPEUTICS, 제26권 5호, pp.481-486
Phloxine O, a Cosmetic Colorant, Suppresses the Expression of Thymic Stromal Lymphopoietin and Acute Dermatitis Symptoms in Mice -
2018.09
| 교신저자
| BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 제503권 3호, pp.2117-2123
Anti-obesity potential of Glycyrrhiza uralensis and licochalcone A through induction of adipocyte browning -
2018.08
| 공동저자
| JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 제1092권, pp.114-121
Simultaneous quantification of 18 saturated and unsaturated fatty acids and 7 sterols as their tert-butyldimethylsilyl derivatives in human saliva using gas chromatography-tandem mass spectrometry -
2018.08
| 공동저자
| JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY, 제64권, pp.300-310
Dual-functionalized calcium nanocomplexes for transfection of cancerous and stem cells: Low molecular weight polycation-mediated colloidal stability and ATP-mediated endosomal release -
2018.08
| 공동저자
| FRONTIERS IN PHARMACOLOGY, 제9권
Mitochondrial-targeting anticancer agent conjugates and nanocarrier systems for cancer treatment -
2018.07
| 공동저자
| BIOMACROMOLECULES, 제19권 7호, pp.2483-2495
Effects of the Physicochemical, Colloidal, and Biological Characteristics of Different Polymer Structures between α-Poly(l -lysine) and ϵ-Poly(l -lysine) on Polymeric Gene Delivery -
2018.04
| 교신저자
| RHEUMATOLOGY, 제57권 4호, pp.727-736
Suppression of NLRP3 inflammasome by oral treatment with sulforaphane alleviates acute gouty inflammation -
2018.04
| 공동저자
| JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 제1083권, pp.68-74
Metabolomics-assisted metabolite profiling of itraconazole in human liver preparations -
2018.03
| 공동저자
| CELL DEATH & DISEASE, 제9권 3호, pp.401-401
Kaempferol targeting on the fibroblast growth factor receptor 3-ribosomal S6 kinase 2 signaling axis prevents the development of rheumatoid arthritis -
2018.03
| 교신저자
| CHEMICO-BIOLOGICAL INTERACTIONS, 제284권, pp.41-47
Potentiation of skin TSLP production by a cosmetic colorant leads to aggravation of dermatitis symptoms -
2018.08
| 공동저자
| DRUG TESTING AND ANALYSIS, 제10권 8호, pp.1328-1335
Targeted and non-targeted metabolite identification of MAM-2201 in human, mouse, and rat hepatocytes -
2017.10
| 교신저자
| FOOD AND CHEMICAL TOXICOLOGY, 제108권, pp.236-243
Evaluation of ocular irritancy of coal-tar dyes used in cosmetics employing reconstructed human cornea-like epithelium and short time exposure tests -
2017.10
| 교신저자
| TOXICOLOGICAL RESEARCH, 제33권 4호, pp.283-290
Suppression of Primary Splenocyte Proliferation by Artemisia capillaris and Its Components -
2017.05
| 공동저자
| JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 제20권 3호, pp.155-182
Risk assessment of zinc oxide, a cosmetic ingredient used as a UV filter of sunscreens -
2017.02
| 공동저자
| ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 제409권 6호, pp.1667-1680
Metabolic characterization of (1-(5-fluoropentyl)-1H-indol-3-yl)(4-methyl-1-naphthalenyl)-methanone (MAM-2201) using human liver microsomes and cDNA-overexpressed cytochrome P450 enzymes -
2017.01
| 교신저자
| JOURNAL OF LEUKOCYTE BIOLOGY, 제101권 1호, pp.205-215
Oxidized phosphatidylcholine induces the activation of NLRP3 inflammasome in macrophages -
2016.12
| 교신저자
| SCIENTIFIC REPORTS, 제6권, pp.38622-38622
Targeting ASC in NLRP3 inflammasome by caffeic acid phenethyl ester: a novel strategy to treat acute gout -
2016.08
| 공동저자
| EUROPEAN JOURNAL OF PHARMACOLOGY, 제785권, pp.24-35
Mechanisms for the activation of Toll-like receptor 2/4 by saturated fatty acids and inhibition by docosahexaenoic acid -
2016.07
| 공동저자
| JOURNAL OF NUTRITION, 제146권 7호, pp.1411-1419
Postprandial Inflammatory Responses and Free Fatty Acids in Plasma of Adults Who Consumed a Moderately High-Fat Breakfast with and without Blueberry Powder in a Randomized Placebo-Controlled Trial -
2016.05
| 교신저자
| JOURNAL OF INVESTIGATIVE DERMATOLOGY, 제136권 5호, pp.1062-1066
Topical Application of Dieckol Ameliorates Atopic Dermatitis in NC/Nga Mice by Suppressing Thymic Stromal Lymphopoietin Production -
2016.04
| 교신저자
| SCIENTIFIC REPORTS, 제6권
A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet -
2016.02
| 공동저자
| JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 제119권 0호, pp.50-58
In vitro metabolism of a novel synthetic cannabinoid, EAM-2201, in human liver microsomes and human recombinant cytochrome P450s -
2016.01
| 교신저자
| TOXICOLOGICAL RESEARCH, 제32권 1호, pp.1-3
Shedding new lights with the breakthrough ideas to understand current trends in modern toxicology -
2015.10
| 공동저자
| BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 제466권 3호, pp.300-305
The NLRP3 inflammasome is dispensable for ER stress-induced pancreatic beta-cell damage in Akita mice -
2015.08
| 교신저자
| JOURNAL OF ETHNOPHARMACOLOGY, 제172권 0호, pp.254-260
Celastrol blocks binding of lipopolysaccharides to a Toll-like receptor4/myeloid differentiation factor2 complex in a thiol-dependent manner -
2015.07
| 공동저자
| PLOS ONE, 제10권 7호
NRF2 Signaling Negatively Regulates Phorbol-12-Myristate-13-Acetate (PMA)-Induced Differentiation of Human Monocytic U937 Cells into Pro-Inflammatory Macrophages -
2015.07
| 공동저자
| JOURNAL OF IMMUNOLOGY, 제195권 1호, pp.237-245
A Novel Small-Molecule Inhibitor Targeting the IL-6 Receptor beta Subunit, Glycoprotein 130 -
2015.05
| 교신저자
| MOLECULAR CANCER, 제14권
X-shaped DNA potentiates therapeutic efficacy in colitis-associated colon cancer through dual activation of TLR9 and inflammasomes -
2015.04
| 교신저자
| CHEMISTRY & BIODIVERSITY, 제12권, pp.538-546
Suppression of Splenic Lymphocyte Proliferation by Eucommia ulmoides and Genipin -
2015.03
| 교신저자
| CYTOKINE, 제72권, pp.63-70
"A Src-family-tyrosine kinase, Lyn, is required for efficient IFN-beta, expression in pattern recognition receptor, RIG-I, signal pathway by interacting with IPS-1" -
2015.03
| 교신저자
| 한국독성학회지, 제31권 1호, pp.11-16
Gambogic Acid Disrupts Toll-like Receptor4 Activation by Blocking Lipopolysaccharides Binding to Myeloid Differentiation Factor 2 -
2015.02
| 교신저자
| IMMUNOLOGY, 제144권, pp.312-320
Phosphatidylinositol-3-kinase and Akt are required for RIG-I-mediated anti-viral signalling through cross-talk with IPS-1 -
2015.01
| 공동저자
| LANGMUIR, 제31권, pp.912-916
X-DNA Origami-Networked Core-Supported Lipid Stratum -
2014.11
| 교신저자
| MOLECULAR CARCINOGENESIS, 제53권 11호, pp.926-937
PPAR delta Deficiency Disrupts Hypoxia-Mediated Tumorigenic Potential of Colon Cancer Cells -
2014.08
| 공동저자
| TOXICOLOGY LETTERS, 제229권 1호, pp.59-65
Highly expressed protein kinase A inhibitor alpha and suppression of protein kinase A may potentiate acetaminophen-induced hepatotoxicity -
2013.09
| 공동저자
| ADVANCED HEALTHCARE MATERIALS, 제2권 9호, pp.1252-1258
A light-driven anti-cancer dual-therapeutic cassette enhances solid tumour regression -
2013.06
| 교신저자
| INFLAMMATION RESEARCH, 제62권, pp.571-580
Suppression of Toll-like receptor 4 activation by endogenous oxidized phosphatidylcholine, KOdiA-PC by inhibiting LPS binding to MD2 -
2013.05
| 교신저자
| BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 제434권 3호, pp.600-605
Sulforaphane inhibits the engagement of LPS with TLR4/MD2 complex by preferential binding to Cys133 in MD2 -
2013.04
| 교신저자
| INFLAMMATION, 제36권, pp.426-433
Retinol Suppresses the Activation of Toll-Like Receptors in MyD88-and STAT1-Independent Manners -
2013.04
| 교신저자
| BRITISH JOURNAL OF PHARMACOLOGY, 제168권 8호, pp.1933-1945
Suppression of Toll-like receptor 4 activation by caffeic acid phenethyl ester is mediated by interference of LPS binding to MD2 -
2013.03
| 공동저자
| TOXICOLOGY LETTERS, 제218권 1호, pp.39-49
Identification of aldo-keto reductases as NRF2-target marker genes in human cells -
2012.03
| 교신저자
| BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 제419권 3호, pp.466-471
PI3K/Akt contributes to increased expression of Toll-like receptor 4 in macrophages exposed to hypoxic stress
-
2017.01
| 공동
| 신일북스
예방약학 -
2013.01
| 공동
| Elsevier Inc.
Tea in Health and Disease Prevention
-
2023.10.05
| 주발명자
| 가톨릭대학교 산학협력단
파제신을 유효성분으로 포함하는 면역 질환의 예방또는 치료용 약학적 조성물(Pharmaceutical composition for Preventing or Treating Immune Disease Comprising fargesin) -
2023.07.21
| 주발명자
| 가톨릭대학교 산학협력단
세포투과성 Regnase-1 재조합 단백질 및 이를 유효성분으로 함유하는 항염증용 조성물(Cell permeable Regnase-1 recombinant protein and anti-inflammatory composition comprising the same) -
2023.01.02
| 주발명자
| 가톨릭대학교 산학협력단
로가닌을 유효성분으로 함유하는 통풍 예방 또는 치료용 조성물(COMPOSITION FOR PREVENTING OR TREATING GOUT COMPRISING LOGANIN) -
2022.11.24
| 주발명자
| 가톨릭대학교 산학협력단
NLRP3 인플라마좀 억제제 및 이의 용도(NLRP3 INFLAMMASOME INHIBITOR AND USES THEREOF) -
2022.08.03
| 주발명자
| 가톨릭대학교 산학협력단
NLRP3 인플라마좀 억제제 및 이의 용도(NLRP3 INFLAMMASOME INHIBITOR AND USES THEREOF) -
2022.07.21
| 주발명자
| 가톨릭대학교 산학협력단
분지형 DNA 덴드리머 및 환원성 양이온 중합체로 구성된 복합체, 및 상기 복합체를 포함하는 면역 증진용 조성물(A complex consisting of branched DNA dendrimer and reducible polycations, and a composition comprising the complex for enhancing immunity) -
2022.07.04
| 주발명자
| 가톨릭대학교 산학협력단
부타클라몰을 유효성분으로 포함하는 면역 질환의 예방 또는 치료용 약학적 조성물(Pharmaceutical composition for Preventing or Treating Immune Disease Comprising butaclamol) -
2022.06.10
| 주발명자
| 가톨릭대학교 산학협력단
NLRP3 인플라마좀 억제제 및 이의 용도(NLRP3 INFLAMMASOME INHIBITOR AND USES THEREOF) -
2022.06.10
| 주발명자
| 가톨릭대학교 산학협력단
NLRP3 인플라마좀 억제제 및 이의 용도(NLRP3 INFLAMMASOME INHIBITOR AND USES THEREOF) -
2022.05.27
| 주발명자
| 가톨릭대학교 산학협력단
분지형 DNA 덴드리머를 유효성분으로 포함하는 면역 증진용 조성물(A Composition comprising branched DNA dendrimer as an active ingredient for enhancing immunity) -
2021.07.21
| 주발명자
| 가톨릭대학교 산학협력단,대한민국(농촌진흥청장)
로가닌을 유효성분으로 포함하는 비알코올성 지방간 예방 또는 치료용 조성물(Composition for preventing or treating non-alcoholic fatty liver disease comprising loganin) -
2020.01.31
| 주발명자
| 가톨릭대학교 산학협력단
β-카로틴의 NLRP3 PYD 도메인 결합 사이트 및 이를 이용한 통풍 치료제의 스크리닝 방법(Binding sites of β-carotene to NLRP3 PYD domain and screening method for therapeutic agent of gout using same) -
2019.09.25
| 주발명자
| 가톨릭대학교 산학협력단
감초 분획물을 유효성분으로 함유하는 여드름 예방 또는 치료용 조성물(Composition for preventing or treating acne comprising glycyrrhiza fraction) -
2019.07.30
| 주발명자
| 가톨릭대학교 산학협력단,대한민국(농촌진흥청장)
감초 추출 분획물을 유효성분으로 함유하는 비만 예방 또는 치료용 조성물 및 이의 제조방법(Composition for preventing or treating obesity comprising the fraction of Glycyrrhiza uralensis extract and manufacturing method thereof) -
2019.01.03
| 주발명자
| 가톨릭대학교 산학협력단,대한민국 (식품의약품안전처장)
알러지 유발 물질 및 알러지 질환 치료제의 신규한 인 비트로(in vitro) 스크리닝 방법(Novel Method for In Vitro Screening Induction Substance of Allergy and Agent for Treating Allergy Disease) -
2019.01.03
| 주발명자
| 가톨릭대학교 산학협력단,대한민국 (식품의약품안전처장)
알러지 억제 물질 및 알러지 질환 치료제의 신규한 인 비트로(in vitro) 스크리닝 방법(Novel Method for In Vitro Screening Inhibitory Substance of Allergy and Agent for Treating Allergy Disease) -
2018.11.13
| 주발명자
| 가톨릭대학교 산학협력단
X형 구조의 DNA를 유효성분으로 포함하는 아토피 피부염 예방 또는 치료용 조성물 -
2018.08.22
| 주발명자
| 가톨릭대학교 산학협력단,대한민국 (식품의약품안전처장)
알러지 유발 물질 및 알러지 질환 치료제의 신규한 인 비보(in vivo) 스크리닝 방법(Novel Method for In Vivo Screening Induction Substance of Allergy and Agent for Treating Allergy Disease) -
2018.01.17
| 주발명자
| 가톨릭대학교 산학협력단
감보그 산(gambogic acid)을 포함한 알러지성 질환 예방 또는 치료용 조성물(Composition for Preventing or Treating Allergic Disease Comprising Gambogic Acid) -
2017.04.24
| 주발명자
| 가톨릭대학교 산학협력단
인터루킨―1베타 억제제의 스크리닝 방법(Screening method of interleukin-1beta inhibitors) -
2017.01.31
| 주발명자
| 가톨릭대학교 산학협력단
바이오틴이 결합된 카페인산 화합물을 유효성분으로 함유하는 통풍 예방 또는 치료용 조성물(Composition for preventing or treating gout comprising caffeic acid conjugated with biotin) -
2016.09.27
| 주발명자
| 가톨릭대학교 산학협력단
X형 구조의 DNA를 유효성분으로 포함하는 아토피 피부염 예방 또는 치료용 조성물(Composition for preventing or treating atopic dermatitis comprising X structured DNA) -
2015.10.28
| 공동발명자
| 가톨릭대학교 산학협력단
산화 인지질 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물(Compositions for the treatment or prevention of immune diseases comprising inhibitor of oxidized phospholipids) -
2015.04.20
| 주발명자
| 가톨릭대학교 산학협력단
Y형 구조의 DNA를 유효 성분으로 포함하는 면역 및 항암 효과 증진용 조성물(A Composition containing Y structured DNA for enhancing Immunity and Anti-Cancer Effect) -
2015.04.16
| 주발명자
| 가톨릭대학교 산학협력단
X형 구조의 DNA를 유효 성분으로 포함하는 면역 효과 및 항암 효과 증진용 조성물(A Composition containing X structured DNA for enhancing Immunity and Anti-Cancer Effect) -
2014.10.07
| 주발명자
| 가톨릭대학교 산학협력단
카페인산 펜에틸 에스테르를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물(Composition for preventing or treating immune disease comprising Caffeic acid phenethyl ester) -
2013.05.07
| 주발명자
| 광주과학기술원
TLR4 시그널링 억제제의 스크리닝 방법(Methods for Screening TLR4(Toll-like receptor 4) Signaling Inhibitors)
-
2024.11.04
| 주발명자
| (주)티아컴퍼니
'로가닌을 유효성분으로 함유하는 통풍 예방 또는 치료용 조성물'의 기술이전(양도) -
2024.11.04
| 주발명자
| (주)티아컴퍼니
'파제신을 유효성분으로 포함하는 면역 질환의 예방 또는 치료용 약학적 조성물'의 기술이전(양도) -
2024.03.01
| 주발명자
| (주)비앤씨생활건강
'감초 추출 분획물을 유효성분으로 함유하는 비만 예방 또는 치료용 조성물 및 이의 제조방법'의 기술이전 -
2018.04.16
| 주발명자
| ㈜모든바이오
‘인플라마좀 저해제 탐색 방법'의 기술이전 건 -
2016.11.14
| 주발명자
| 감바이오팜
‘감보그 산(gambogic acid)을 포함한 알러지성 질환 예방 또는치료용 조성물’ 기술이전 -
2015.07.27
| 주발명자
| 감바이오팜
베타카로틴을 유효성분으로 함유하는 통풍 예방 또는 치료용 조성물 기술이전